In Hurler syndrome (mucopolysaccharidosis-I; MPS-I, the most common MPS disorder), an inborn deficiency of the lysosomal hydrolase α-L-iduronidase (IDUA) leads to incomplete degradation and lysosomal accumulation of heparan sulfate (HS) and dermatan sulfate (DS) glycosaminoglycans (GAGs; Fig. 1 ) [1] . The mechanisms by which accumulated GAGs cause multiorgan dysfunction, including the devastating neuropsychological manifestations of Hurler syndrome and other mucopolysaccharidoses, remain unclear. The neuropathology of Hurler syndrome includes neuronal loss leading to brain atrophy and formation of ectopic dendrites and synapses [2, 3] . These features cannot be explained simply by the mechanical effect of GAG-distended lysosomes. It is well known that the fibroblast growth factor (FGF) cytokine family mediates cell growth and differentiation, as well as neurogenesis, axonal guidance, and neuronal survival [4, 5, 6] . The interaction of HS with FGF2 and its effect on the biological activity of FGF2 have been studied extensively [7] . In normal cells, structurally specific HS is required for optimal biological activity of FGF2 [8] , by formation of the "FGF2-FGF-receptor-HS" complex [9, 10] . One structural feature required for facilitation of FGF2 activity is 6-O-sulfation of HS [11, 12] . However, the consequences of structurally abnormal HS in a disease state on FGF2 activity and their contribution to disease pathophysiology have not been defined. We hypothesized that the functional properties of the abnormal-sized and sulfated HS in Hurler syndrome are defective, and that this leads to aberrant modulation of the biological activity of GAG-binding cytokines such as the FGFs, thereby contributing to the pathophysiology of Hurler syndrome (Fig. 2) . Until recently, a major impediment to examining the developmental role of HS in vitro has been the lack of primary progenitor cells capable of differentiation into neuronal and other cell types representative of tissues affected by Hurler syndrome. This limitation has been removed by a major advance in cell biology: the isolation and culture of a multipotent, nonhematopoietic stem cell from human and rodent bone marrow (the multipotent adult progenitor cell: MAPC) capable of extensive expansion, and in vitro and in vivo differentiation into endodermal, mesodermal, and neuroectodermal cells representing all three embryonic lineages [13, 14, 15] . MAPCs, therefore, provide an excellent in vitro model of development for studying the effect of HS on cytokinemediated differentiation.
We used MAPC derived from normal donors and patients with Hurler syndrome to examine the structure and the functional properties of Hurler HS in our recent publication [16] . Using metabolic labeling of GAGs, we showed that the HS that accumulates in Hurler MAPC contained a large proportion of small (M r 5.5 kDa) polysaccharide chains. HPLC of fluorescently labeled disaccharides showed that the disaccharide composition of accumulated HS in Hurler MAPC was also markedly abnormal. While both normal and Hurler HS were comprised of the six major disaccharide types, the proportions of all three 6-O-sulfated disaccharides (UAGlcNAc6S, UAGlcNS6S, and UA2SGlcNS6S) were lower in Hurler HS. There was a progressive decline in the proportion of UAGlcNS6S (up to 84%) with increasing total accumulation of GAGs (correlation coefficient R = 0.99). This novel observation suggests that the structural aberration of HS in Hurler syndrome may continue to worsen with progression of the disease.
Our studies also demonstrated that the binding affinity of Hurler HS (containing lower proportions of 6-O-sulfated disaccharides) was reduced, which directly impaired the biological activity of FGF2. Li et al. [17] recently reported that proliferation of neural progenitors (which depends on FGF2) is reduced in the subventricular zone of the brain of MPS-IIIB mice. Our in vitro observations are consistent with this in vivo phenomenon and together indicate that structurally abnormal HS hampers the mitogenic response of neural progenitors to GAG-binding cytokines. Patients with Hurler syndrome are clinically normal at birth, but develop progressive multisystem dysfunction starting in early childhood, with increasing tissue accumulation of GAGs. Our observation that increasing accumulation of total HS in Hurler MAPC is associated with progressive reduction in the UAGlcNS6S disaccharide leads to an interesting speculation: in the prenatal and early postnatal period, when tissue accumulation of GAGs is less, the structure of HS may not be abnormal enough to impair the biological activity of cytokines and morphogens required for embryogenesis and fetal development. However, as tissue GAG accumulation increases in infancy and early childhood, the structural abnormalities in HS worsen, leading to defective cytokine activity and the development of clinical features such as progressive mental retardation and other manifestations of neuronal dysfunction. Indeed, a recent study [18] showed that the higher levels of one specific HS and one specific DS trisaccharide in skin fibroblasts obtained from Hurler patients correlated with neuropathology. Importantly, this correlation was evident only after prolonged culture of the cells and progressive GAG accumulation.
The potential clinical implications of modulation of cytokine and chemokine function by HS proteoglycans are being increasingly appreciated [19] . Our studies may be indicative of a mechanism by which structurally and functionally abnormal HS directly contribute to disease pathophysiology and development, by perturbing the biological activity of critical cytokines and morphogens. These data also suggest that replacement of structurally abnormal HS by normal HS can restore cytokine signaling and biological response in neurodegenerative diseases where GAGs accumulate. The successful biochemical and functional cross-correction induced by normal MAPC also provide the rationale for therapeutic trials of normal or gene-corrected MAPC, which might serve as a source of missing enzyme(s) and directly differentiate into and replace lost neuronal and other cell types. 
